Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
for
Preterm Delivery, Obstetrical Complications
Location: Philadelphia PA, New York NY, Providence RI,
Sponsor: The George Washington University Biostatistics Center
Sex: Female
Age: 14+
Code: NCT06980025
Phase 3, Recruiting
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
for
Acute Ischemic Stroke From Large Vessel Occlusion
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT06904911
Phase 2, Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
for
Cystic Fibrosis Lung
Location: Philadelphia PA, Baltimore MD, Richmond VA, Boston MA,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 18+
Code: NCT05248230
Phase 2, Recruiting
COPD Exacerbation Follow Up
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Philadelphia PA, Cherry Hill NJ, Park Ridge IL
Sponsor: Viz.ai, Inc.
Sex: All
Age: 40+
Code: NCT07118306
Recruiting
Neuralert Stroke Monitor Trial
for
Surgery, Stroke
Location: Philadelphia PA
Sponsor: Neuralert Technologies LLC
Sex: All
Age: 22+
Code: NCT07362303
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Randomized Assessment of TcMS for VT Storm
for
Ventricular Tachycardia
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT05599022
Recruiting
Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
for
Head and Neck Cancer, Head and Neck Small Cell Carcinoma,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18+
Code: NCT07501650
Phase 1, Recruiting
Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study
for
Peripheral Neuropathy
Location: Philadelphia PA
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Sex: All
Age: 18+
Code: NCT07501663
Recruiting
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
for
Lung Cancer, Lung Metastases
Location: Philadelphia PA, Ann Arbor MI, Rochester MN, Orlando FL,
Sponsor: Vergent Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07499674
Phase 3, Recruiting
Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity
for
Morbidity;Perinatal
Location: Phialdelphia PA
Sponsor: University of Pennsylvania
Sex: Female
Age: 16 - 55
Code: NCT06245057
Recruiting
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Philadelphia PA, San Antonio TX
Sponsor: Immune Control
Sex: All
Age: 18+
Code: NCT00821301
Phase 1, Recruiting
FTT PET/CT in Metastatic Prostate Cancer
for
Prostate Cancer Metastatic
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: Male
Age: 18+
Code: NCT05242744
Early Phase 1, Recruiting
Physiologic MR Imaging of Salivary Gland Tumors
for
Salivary Gland Tumor
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT04452162
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Location: Philadelphia PA, Morristown NJ, New York NY,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06445062
Phase 1, Phase 2, Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
for
PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer
Location: Philadelphia PA, Long Island City NY, Columbus OH,
Sponsor: Whitehawk Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07470853
Phase 1, Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy